Drug · DIN 01924516
DEXEDRINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 25, 2026; first marketed December 31, 1992.
- Drug Identification Number (DIN)
- 01924516
- Company (DIN owner)
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Schedule
- Controlled drugs (CDSA I)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Dexamfetamine N06BA02
- Class
- Human
- Record last updated
- February 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEXTROAMPHETAMINE SULFATE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 25, 2026: NOC 36966New Drug Submission (NDS) · Administrative: Change in product ownership
- November 6, 2024: NOC 34335New Drug Submission (NDS) · Change in product ownership
- March 22, 2016: NOC 17906New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “dexedrine”. A notice may cover another product or only some lots: read it to see what it covers.
- Dexedrine Spansule SRC 10MG (2020-08-28)August 28, 2020 · Drugs · Product safety · Type II